Physician profile
Amanda Higgins
NPI 1376183426
$4,655.65
in general payments reported to CMS, 2019-2025
40 companies · $989 in 2025
The $989 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $772 · 2022: $841 · 2023: $953 · 2024: $1,102 · 2025: $989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,978 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,978.10 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,220.85 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $340.31 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $305.54 | 2021-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $274.48 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $244.52 | 2021-2025 | Evenity, Prolia, Otezla |
| Novo Nordisk INC | $219.87 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $212.52 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $185.18 | 2021-2025 | |
| Pfizer INC. | $164.47 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.15 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $126.24 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sunovion Pharmaceuticals INC. | $103.36 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $88.69 | 2022-2023 | Livalo, Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $86.80 | 2022-2024 | |
| Exact Sciences Corporation | $79.80 | 2023-2025 | Cologuard Collection Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.